Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold
Status:
Unknown status
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the non-inferiority of Coristina® d in the
symptomatic treatment of the common cold compared to Resfenol® comparator.